Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.

NVP-TAE 684 [761439-42-3]

Imprimer

Référence HY-10192-5mg

Conditionnement : 5mg

Marque : MedChemExpress

Demander plus d'informations

Description

NVP-TAE 684 (TAE 684) is a highly potent and selective ALK inhibitor, which blocks the growth of ALCL-derived and ALK-dependent cell lines with IC₅₀ values between 2 and 10 nM^[1].

IC₅₀ & Target

IC50: 2-10 nM (ALK-dependent cell lines)^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
BaF3	GI₅₀	1.1 μM Compound: 14; TAE684	Antiproliferative activity against mouse BAF3 cells after 72 hrs by CellTiter-Glo assay Antiproliferative activity against mouse BAF3 cells after 72 hrs by CellTiter-Glo assay	[PMID: 28850922]
BaF3	IC₅₀	0.001 μM Compound: 1, TAE684	Cytotoxicity against mouse BAF3 cells expressing Tel-ALK after 48 hrs by CellTiter-Glo assay Cytotoxicity against mouse BAF3 cells expressing Tel-ALK after 48 hrs by CellTiter-Glo assay	[PMID: 21572589]
BaF3	IC₅₀	0.004 μM Compound: TAE-684	Inhibition of Tel-fused ALK kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused ALK kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	0.02 μM Compound: 1, TAE684	Cytotoxicity against mouse BAF3 cells expressing EML4-ALK after 48 hrs by MTS assay Cytotoxicity against mouse BAF3 cells expressing EML4-ALK after 48 hrs by MTS assay	[PMID: 21572589]
BaF3	IC₅₀	0.06 μM Compound: 1, TAE684	Cytotoxicity against mouse BAF3 cells expressing ALK F1174L mutant coexpressing EML4 after 48 hrs by MTS assay Cytotoxicity against mouse BAF3 cells expressing ALK F1174L mutant coexpressing EML4 after 48 hrs by MTS assay	[PMID: 21572589]
BaF3	IC₅₀	0.08 μM Compound: 1, TAE684	Cytotoxicity against mouse BAF3 cells expressing ALK L1196M mutant coexpressing EML4 after 48 hrs by MTS assay Cytotoxicity against mouse BAF3 cells expressing ALK L1196M mutant coexpressing EML4 after 48 hrs by MTS assay	[PMID: 21572589]
BaF3	IC₅₀	0.554 μM Compound: TAE-684	Inhibition of Tel-fused FLT3 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused FLT3 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	0.872 μM Compound: TAE-684	Inhibition of Tel-fused FLT1 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused FLT1 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.048 μM Compound: TAE-684	Inhibition of Tel-fused Abl kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused Abl kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.146 μM Compound: TAE-684	Inhibition of Tel-fused SRC kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused SRC kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.167 μM Compound: TAE-684	Inhibition of Tel-fused Tie2 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused Tie2 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.216 μM Compound: TAE-684	Inhibition of Tel-fused FGFR1 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused FGFR1 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.3 μM Compound: TAE-684	Inhibition of Tel-fused EphB4 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused EphB4 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.308 μM Compound: TAE-684	Inhibition of Tel-fused Lyn kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused Lyn kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.313 μM Compound: TAE-684	Inhibition of Tel-fused KitQ kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused KitQ kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.385 μM Compound: TAE-684	Inhibition of Tel-fused RET kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused RET kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.474 μM Compound: TAE-684	Inhibition of Tel-fused Syk kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused Syk kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.505 μM Compound: TAE-684	Inhibition of Tel-fused JAK2 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused JAK2 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.578 μM Compound: TAE-684	Inhibition of Tel-fused Bmx kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused Bmx kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.598 μM Compound: TAE-684	Inhibition of Tel-fused ZAP70 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused ZAP70 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.634 μM Compound: TAE-684	Inhibition of Tel-fused RON kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused RON kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1.667 μM Compound: TAE-684	Inhibition of Tel-fused MET kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused MET kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	1336 nM Compound: 4, TAE684	Cytotoxicity against mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay Cytotoxicity against mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	[PMID: 23742252]
BaF3	IC₅₀	2 nM Compound: TAE684	Inhibition of ROS1 (unknown origin) expressed in mouse BA/F3 cells Inhibition of ROS1 (unknown origin) expressed in mouse BA/F3 cells	[PMID: 25461320]
BaF3	IC₅₀	2.018 μM Compound: TAE-684	Inhibition of Tel-fused TRKB kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused TRKB kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	2.123 μM Compound: TAE-684	Inhibition of Tel-fused KDR kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused KDR kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	2.309 μM Compound: TAE-684	Inhibition of Tel-fused TYK2 kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused TYK2 kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	2.751 μM Compound: TAE-684	Inhibition of mouse wild type BaF3/WT Luc+ cell proliferation Inhibition of mouse wild type BaF3/WT Luc+ cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	229.3 nM Compound: 18; TAE684	Cytotoxicity against mouse BaF3 cells expressing human EGFR C797S/del19 mutant assessed as inhibition of in cell viability measured after 72 hrs by CellTiter-Glo assay Cytotoxicity against mouse BaF3 cells expressing human EGFR C797S/del19 mutant assessed as inhibition of in cell viability measured after 72 hrs by CellTiter-Glo assay	[PMID: 33243531]
BaF3	IC₅₀	229.3 nM Compound: 8	Cytotoxicity against mouse BaF3 cells expressing EGFR-Del19/C797S mutant assessed as cell growth inhibition incubated for 72 hrs by Celltiter-Glo assay Cytotoxicity against mouse BaF3 cells expressing EGFR-Del19/C797S mutant assessed as cell growth inhibition incubated for 72 hrs by Celltiter-Glo assay	[PMID: 36417820]
BaF3	IC₅₀	3 nM Compound: 1, TAE684	Cytotoxicity against mouse BAF3 cells expressing NPM-ALK after 48 hrs by CellTiter-Glo assay Cytotoxicity against mouse BAF3 cells expressing NPM-ALK after 48 hrs by CellTiter-Glo assay	[PMID: 21572589]
BaF3	IC₅₀	3.22 μM Compound: TAE-684	Inhibition of Tel-fused PDGFRb kinase-mediated mouse BaF3 cell proliferation Inhibition of Tel-fused PDGFRb kinase-mediated mouse BaF3 cell proliferation	[PMID: 17185414]
BaF3	IC₅₀	3.7 nM Compound: 4, TAE684	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	[PMID: 23742252]
BaF3	IC₅₀	340.7 nM Compound: 18; TAE684	Cytotoxicity against mouse BaF3 cells expressing human EGFR C797S/T790M/del19 mutant assessed as inhibition of in cell viability measured after 72 hrs by CellTiter-Glo assay Cytotoxicity against mouse BaF3 cells expressing human EGFR C797S/T790M/del19 mutant assessed as inhibition of in cell viability measured after 72 hrs by CellTiter-Glo assay	[PMID: 33243531]
BaF3	IC₅₀	340.7 nM Compound: 8	Cytotoxicity against mouse BaF3 cells harboring EGFR C797S/T790M/del19 mutant assessed as growth inhibition incubated for 72 hrs by CellTiter-Glo assay Cytotoxicity against mouse BaF3 cells harboring EGFR C797S/T790M/del19 mutant assessed as growth inhibition incubated for 72 hrs by CellTiter-Glo assay	[PMID: 36417820]
BaF3	IC₅₀	43.7 nM Compound: 4, TAE684	Inhibition of TEL-fused insulin receptor (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay Inhibition of TEL-fused insulin receptor (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	[PMID: 23742252]
HEK293	IC₅₀	21.9 nM Compound: TAE684	Inhibition of LRRK2 G2019S and A2016T mutant expressed in HEK293 cells using nictide and ATP as substrate Inhibition of LRRK2 G2019S and A2016T mutant expressed in HEK293 cells using nictide and ATP as substrate	[PMID: 22335897]
HEK293	IC₅₀	6.1 nM Compound: TAE684	Inhibition of LRRK2 G2019S mutant expressed in HEK293 cells using nictide and ATP as substrate Inhibition of LRRK2 G2019S mutant expressed in HEK293 cells using nictide and ATP as substrate	[PMID: 22335897]
HEK293	IC₅₀	7.8 nM Compound: TAE684	Inhibition of wild-type LRRK2 expressed in HEK293 cells using nictide and [gamma32]ATP as substrate Inhibition of wild-type LRRK2 expressed in HEK293 cells using nictide and [gamma32]ATP as substrate	[PMID: 22335897]
HEK293	IC₅₀	93.3 nM Compound: TAE684	Inhibition of LRRK2 A2016T mutant expressed in HEK293 cells using nictide and ATP as substrate Inhibition of LRRK2 A2016T mutant expressed in HEK293 cells using nictide and ATP as substrate	[PMID: 22335897]
KARPAS-299	IC₅₀	<10 nM Compound: TAE-684	Decrease in ALK phosphorylation in human Karpas299 cells after 4 hrs Decrease in ALK phosphorylation in human Karpas299 cells after 4 hrs	[PMID: 17185414]
KARPAS-299	IC₅₀	13 nM Compound: 2, NVP-TAE684	Antiproliferative activity against ALK-dependent human KARPAS299 cells after 72 hrs Antiproliferative activity against ALK-dependent human KARPAS299 cells after 72 hrs	[PMID: 24900831]
KARPAS-299	IC₅₀	14 nM Compound: 7; TAE684	Antiproliferative activity against human ALK-positive KARPAS299 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution cell proliferation assay Antiproliferative activity against human ALK-positive KARPAS299 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution cell proliferation assay	[PMID: 27144831]
KARPAS-299	IC₅₀	2 nM Compound: TAE-684	Antiproliferative activity against human Karpas299 cells assessed as luciferase expression after 72 hrs Antiproliferative activity against human Karpas299 cells assessed as luciferase expression after 72 hrs	[PMID: 17185414]
KARPAS-299	IC₅₀	2.4 nM Compound: 4, TAE684	Cytotoxicity against human KARPAS299 cells after 2 to 3 days by luciferase reporter gene assay Cytotoxicity against human KARPAS299 cells after 2 to 3 days by luciferase reporter gene assay	[PMID: 23742252]
KARPAS-299	IC₅₀	3 nM Compound: TAE-684	Induction of apoptosis in human Karpas299 cells by annexin V assay Induction of apoptosis in human Karpas299 cells by annexin V assay	[PMID: 17185414]
Kelly	IC₅₀	0.38 μM Compound: 1, TAE684	Cytotoxicity against human Kelly cells expressing ALK F1174L mutant Cytotoxicity against human Kelly cells expressing ALK F1174L mutant	[PMID: 21572589]
NCI-H1975	GI₅₀	0.72 μM Compound: 14; TAE684	Growth inhibition of human NCI-H1975 cells after 72 hrs by CellTiter-Glo assay Growth inhibition of human NCI-H1975 cells after 72 hrs by CellTiter-Glo assay	[PMID: 28850922]
NCI-H2228	IC₅₀	16 nM Compound: 2; NVP-TAE684	Inhibition of EML4/ALK in human NCI-H2228 cells Inhibition of EML4/ALK in human NCI-H2228 cells	[PMID: 31419130]
NCI-H3122	IC₅₀	44 nM Compound: 2; NVP-TAE684	Inhibition of EML4/ALK in human NCI-H3122 cells Inhibition of EML4/ALK in human NCI-H3122 cells	[PMID: 31419130]
SH-SY5Y	IC₅₀	0.16 μM Compound: 1, TAE684	Cytotoxicity against human SH-SY5Y cells expressing ALK F1174L mutant Cytotoxicity against human SH-SY5Y cells expressing ALK F1174L mutant	[PMID: 21572589]
SU-DHL-1	IC₅₀	2 nM Compound: TAE-684	Antiproliferative activity against human SUDHL1 cells assessed as luciferase expression after 72 hrs Antiproliferative activity against human SUDHL1 cells assessed as luciferase expression after 72 hrs	[PMID: 17185414]

In Vitro

TAE684 inhibits the proliferation of Ba/F3 NPM-ALK cells with an IC₅₀ of 3 nM, without affecting the survival of parental Ba/F3 cells at concentrations up to 1 μM. TAE684 inhibits STAT3 and STAT5 phosphorylation in a dose-dependent manner in both Ba/F3 NPM-ALK and Karpas-299 cells. TAE684 induces apoptosis and G1 phase arrest in NPM-ALK-expressing Ba/F3 cells and ALCL patient cell lines^[1].
NVP-TAE684 markedly reduces cell survival in both sensitive H3122 and H3122 CR cells, but has little to no effect on the viability of other, non-ALK-dependent cancer cell lines. NVP-TAE684 treatment of H3122 CR cells suppresses phosphorylation of ALK, AKT, and ERK and induces marked apoptosis.
TAE684 potently suppresses the survival of Ba/F3 cells expressing the EML4-ALK L1196M mutant^[2].
Neurite outgrowth induced by expression of the mALKR1279Q mutant is completely inhibited at 30 nM NVP-TAE684, which is comparable with the response seen with activated wt mALK^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Solvant et solubilité

In Vitro:

DMSO : 7.69 mg/mL (12.52 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.6281 mL	8.1407 mL	16.2813 mL
5 mM	0.3256 mL	1.6281 mL	3.2563 mL
10 mM	0.1628 mL	0.8141 mL	1.6281 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 0.77 mg/mL (1.25 mM); Clear solution

This protocol yields a clear solution of ≥ 0.77 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 0.77 mg/mL (1.25 mM); Clear solution

This protocol yields a clear solution of ≥ 0.77 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

Pureté et documentation

Purity: 99.70%

Fiche technique (281 KB) SDS (396 KB)

COA (251 KB) LCMS (95 KB)

Instruction de manipulation (2659 KB)

Références

[1]. Galkin AV, et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):270-5. [Content Brief]

[2]. Katayama R, et al. Therapeutic strategies to overcome PF-02341066 resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7535-40. [Content Brief]

[3]. Schonherr C, Activating ALK mutations found in neuroblastoma are inhibited by PF-02341066 and NVP-TAE684. Biochem J. 2011 Dec 15;440(3):405-13. [Content Brief]

Vous serez peut-être également intéressé par les produits suivants :

Référence

Description

Cond.

Prix HT

HY-13020-5mg

GSK1838705A [1116235-97-2]

5mg

HY-13011-5mg

Alectinib [1256580-46-7]

5mg

HY-13326-5mg

ASP3026 [1097917-15-1]

5mg

NVP-TAE 684 [761439-42-3]

Référence HY-10192-5mg

Marque : MedChemExpress

NVP-TAE 684 Related Antibodies

Vous serez peut-être également intéressé par les produits suivants :